Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2025 Nov 14;5(11):e0004003. doi: 10.1371/journal.pgph.0004003

Recommendations for screening of MetS: Utilizing total cholesterol for trend and prevalence estimates of Metabolic Syndrome among adults-findings from STEPS survey of Nepal

Bhawana Bhandari 1, Bihumgum Bista 2, Suna Laxmi Karmacharya 3, Anil Babu Ojha 4, Suresh Mehata 5, Mariani Ahmad Nizaruddin 1,6,*
Editor: Julia Robinson7
PMCID: PMC12617954  PMID: 41237185

Abstract

The global prevalence of Metabolic Syndrome (MetS)is rising, underscoring the significant burden of cardiovascular morbidity and mortality. Most studies on MetS focus on clinical aspects however, to reduce the burden of cardiovascular disease, periodic screening for MetS is essential along with cost-effective measures that can be implemented on a community basis. The study was a population-based retrospective cross-sectional STEPwise surveillance (STEPS) conducted in three ecological regions of Nepal in 2013 and 2019.A multistage cluster sampling technique was employed to select the sample. Altogether 3473 and 5051 participants were selected from 2013 and 2019 STEPS survey data. Anthropometric measurements, blood pressure readings and fasting blood test for chemical analysis were collected. A conventional measurement criterion was used to determine the prevalence of MetS utilizing Total Cholesterol. Data analysis was performed using STATA version 16.1. ROC curve model, bivariate and multivariate logistic regression model was used for analysis. The results indicated a decline in the prevalence of MetS from 14.1% in 2013 to 6.69% in 2019. However, MetS remains prevalent. The overall prevalence of MetS was 6.69% with women affected nearly twice as often as men (8.62% compared to 4.57%). Significant differences in MetS prevalence were observed based on age, sex, educational level, marital status, wealth quintile and ecological region. High Waist Circumference among women and hypertension among men was prevalent component in MetS. The prevalence and components of MetS among women are significant. Women are at risk for developing MetS indicating an urgent need for lipid profile screening and educational programs aimed at enhancing women’s lifestyle choices. Cost-effective screening measures for MetS are recommended utilizing Total Cholesterol. The current health Plan should consider incorporating MetS screening into the World Health Organization’s Package of Essential Non-communicable diseases modules to reduce the burden of cardiovascular disease.

Introduction

Worldwide cardiovascular-related mortality and disease burden is significant with annually 17.9 million deaths attributed to cardiovascular disease (CVD) [1,2]. In Nepal, CVD accounts for 16% of total mortality [3]. Behavioral and metabolic or biological risk have been identified as prevalent contributors to Non-Communicable Diseases which can be mitigated through the identification and management of these risk factors [4,5].

Metabolic Syndrome (MetS) is a cluster of metabolic risk factors that include central obesity, dysglycemia, dyslipidemia and elevated blood pressure [6,7]. Metabolic Syndrome increase the risk of Cardio-vascular disease (CVD), type 2 Diabetes Mellitus, stroke and sudden cardiac death with a 10-year risks of Mets estimated at 20–30% [8–12]. The rising prevalence of Metabolic Syndrome in Southeast Asia including Nepal, is a significant public health concern. The most recent STEPS survey conducted in Nepal in 2013 reported a high prevalence of MetS [13–16]. The substantial and trending disease burden of cardiovascular disorders necessitates global public health measures such as screening to identify individuals at high risk [17]. Although the etiology of MetS is not fully understood several lifestyles, behavioral and genetic factors have been associated with its prevalence. Screening for MetS, lifestyle modifications and effective communication upon identification are crucial steps in reducing the incidence of MetS [18,19]. Identifying risk factors among Nepalese population will aid in alleviating the cardiovascular disease burden associated with MetS.

Nepal lacks routine surveillance; a registry system and nationally representative findings related to MetS necessary for informed policy making [20]. Additionally, data on recent trends is unavailable. Therefore, population-based, evidence-based study of Mets is urgently needed to develop effective strategies and health related policies. National health plan addresses the burden of Non communicable disease but places less importance to MetS due to insufficient evidence. This study aims to determine the trends and prevalence of MetS as well as its associated factors and the prevalence of its components triad to mitigate the cardiovascular burden. By highlighting the significance of MetS policy making and implementation, the study will provide recommendations for programs such as the World Health Organization’s Package of Essential Non-Communicable Diseases to effectively manage the burden of Non communicable disease.

Materials and methods

Study design

This study was a population-based retrospective, cross-sectional STEPwise Surveillance conducted across three ecological regions of Nepal. A trend analysis of Metabolic Syndrome was performed using data from the 2013 and 2019 STEPS utilizing Total Cholesterol (TC) levels.

Study population, sample selection and approval

This study conducted a secondary analysis of data from STEPS 2013 and 2019 to estimate the prevalence and trends of MetS. The same parameters were utilized to measure the Prevalence of Mets as outlined in the STEPS “S1 Table.”

In brief, the STEPS survey 2013 was a cross-sectional study conducted from 01/7/2012–30/6/2013.Participants were selected using probability proportionate to size sampling from three ecological regions. A total of 3729 participants met the inclusion criteria and participated in STEP I, STEP II and STEP III phases. Written consent and assent were obtained prior to the study. Further details regarding the methodology are given elsewhere [21]. In the 2019 STEPS Survey, multistage-cluster sampling technique was employed to select 5,593 individuals from three ecological regions. Household listing and mapping were conducted from 06/09/2018–6/12/2018. Participant recruitment for data collection took place from 09/02/2019 till 08/05/2019. The response rates for STEP I, STEP II, STEP III Survey were 86.7% (5593), 86.5% (5582) and 82.6% (5350). A total of 5,051 individuals met the criteria for the study. Participants who underwent STEP I (socio-demographic and behavioral characteristics) STEP II (measurement height, weight and blood pressure) and STEP III (blood sugar measurement, sodium level assessment in urine and blood cholesterol analysis) were considered as inclusive criteria for the analysis. The study was conducted in accordance with the Declaration of Helsinki and procedures involving human subjects were approved by the Nepal Health Research Council. Detailed information on anthropometric and biochemical measurement is provided elsewhere [22–24].

Ethics statement

The agreement for utilization of raw data from the STEPS Survey 2019 was finalized and accessed on 29/7/2022 from Nepal Health Research Council. Additionally, STEPS survey 2013 data was accessed from the WHO Repository on 20/11/2022. The link to the data is provided [25].

Variable definition.

  • Dependent variable Prevalence estimates of Metabolic Syndrome.

  • Independent variable: Two primary predictor variables (factors) were included:

    • i)

      Socio-Demographic Factors: Age in completed years (15–29,30–44 and 45–69), sex (male and female), marital status (never married, currently married and divorced/widowed/separated), education level(no formal schooling, primary, secondary and higher education),wealth quintile(poorest,second,third,fourth and richest),ecological zone (Mountain, Hill and Terai/ plains) and place of residence (urban and rural).

    • ii)

      Behavioral Factors: Current tobacco consumption, alcohol consumption in the past 12 months and the past 30 days, intake of fruits and vegetables(sufficient/insufficient) and the physical activity levels (sufficient/insufficient) “S2 Table”.

Statistical analysis

STATA version 15.1 was employed to analyze the data using survey (svy) set command, which incorporates information on clusters and sampling weights. Population estimates were derived by applying sample weights to all estimates and are reported with 95% Confidence Intervals (CIs). Taylor series linearization calculated the prevalence rate with 95% Confidence Intervals. The study examines trends in the prevalence of Metabolic Syndrome (MetS) comparing data from 2019 to 2013. Mets is defined the presence of a triad consisting of high total cholesterol levels, elevated blood sugar, high blood pressure and increased waist circumference “S1 Table”. Receiver Operating Characteristic (ROC) Curve analysis revealed an Area Under the Curve (AUC) of 0.75 for Total Cholesterol predicting triglyceride (p < 0.001)] “S1 Fig” and Area Under the Curve of 0.71 for Total Cholesterol predicting high density lipoprotein –cholesterol (HDL-C) (p < 0.001) “S2 Fig”. Chi-square test indicated a significant association between total cholesterol and both triglycerides and HDL-C (p < 0.001) “S3 Table”, “S4 Table”, “S5 Table”. Correlation analysis between total cholesterol, triglycerides and (HDL-C) “S6 Table” supporting the notion that increased total cholesterol can serve as a predictor for elevated triglycerides and HDL-C. Chi-Square and bivariate logistic regression analyses were conducted to calculate the unadjusted prevalence ratios (COR) for each risk factors of Metabolic Syndrome in relation to socio-demographic and behavioral covariates including age, sex, education level, marital status, wealth quintile, ecological regions and place of residence. Multivariate logistic regression analysis was used to determine the adjusted odd ratios (AOR). The relationship between the number of risk factors and covariates was assessed through adjusted odd ratios (AOR), with the count of risk factors designated as the dependent variable. Clustering analysis of Metabolic Syndrome was performed by summing the number of risk factors present for each participant ranging from 0 to 4. A p-value ≤ 0.05 was considered as statistically significant.

Global inclusivity

To our knowledge, this is the sole trend study in Nepal addressing the prevalence of Metabolic Syndrome. Following statistical analysis, it is recommended that screening for MetS should focus on Total Cholesterol rather than its individual components due to the cost effectiveness of this approach. Furthermore, additional information on MetS with socio-economic factors was included which was recommended from the previous study in 2013 [15]. This finding suggests that wealth quintile serves as a determinant of Mets in developing countries contributing to cardiovascular related mortality and morbidity.

Results

Trend in the prevalence of Metabolic Syndrome between 2013 and 2019

The graph presented below as ““Fig 1”” illustrates the declining trend in the prevalence of Metabolic Syndrome. The prevalence decreased from 14.1% (95% CI) in 2013 to 6.69% (95% CI) in 2019, representing a reduction of more than half.

Fig 1. Trend in the prevalence of Metabolic Syndrome from 2013 to 2019.

Fig 1

There is a decrease in trend in the prevalence of Metabolic Syndrome from 2013 to 2019(95% CI).

Bivariate analysis for association of Metabolic Syndrome with socio-demographic factors

Socio-demographic characteristics of the participants are summarized in Table 1. Participants’ age ranged from 15 to 69 years. Majority (38.07%) of the participants were aged from 45-69 years. More than half (64.28%) of the participants were female. Almost (84.80%) participants were married, and nearly half of the participants (46.44%) reside in Hilly region. 29% had lowest wealth quintile. Half of the participants (50.2%) had none/primary level education. Majority of the participants (87.78%) were from rural areas.

Table 1. Bivariate analysis of association between Metabolic Syndrome and socio-demographic and behavioral Factors, n = 5051.

Socio-demographic Variable Metabolic Syndrome p-value
COR (Odds Ratio (COR)Odds Ratio
Age No Unadjusted), 95%CI Yes Unadjusted, 95%CI
 15-29 1262(97.61) [96.11,98.54] 25(2.38%) [1.456,3.894] <0.001***
 30-44 1690(91.51%) [89.53,93.15] 151(8.48%) [6.847,10.47]
 45-69 1671(88.05%) [85.72,90.04] 252(11.95%) [9.957,14.28]
Sex
 Men 1704(95.43%) [93.82,96.63] 100(4.56%) [3.371,6.177] <0.001***
 Women 2919(91.38%) [89.79,92.74 328(8.64%) [7.262,10.21]
Education
 None/<Primary 2279(91.9) [0.53,0.93] 257(8.81) [1.08, 1.87] 0.018**
 Primary 879(93.42) [1.06, 1.85] 70(6.58) [0.54, 0.94]
 Secondary 915(95.37) [0.79, 1.59] 65(4.63) [0.63, 1.26]
 >Secondary 549(95.31) [0.81, 1.85] 36(4.69) [0.54, 1.24]
Marital Status
 Never married 477(97.49) [0.014, 0.035] 10(2.51) [0.011,0.039] 0.001***
 Currently married 3907(92.49) [2.43, 8.66] 376(7.51) [0.12, 0.41]
 Divorced/separated/widow 238(86.4) [0.06, 0.24] 43(13.6) [0.06, 0.24]
Wealth Quintile
 Poor 1437 (96.52) [94.78,97.69] 56 (3.47) [2.307,5.216] <0.001***
 Second 912 (95.44) [93.84,96.65] 56 (4.55) [3.354,6.163]
 Third 782 (93.93) [91.28,95.81] 73 (6.07) [4.189,8.723]
 Fourth 703 (92.37) [89.56,94.47] 87 (7.62) [5.526,10.44]
 Richest 789 (88.22) [84.5,91.15] 156(11.78) [8.852,15.5]
Ecological Region
 Mountain 585(97.43%) [95.66,98.49] 18(2.57%) [1.513,4.345] 0.003**
 Hill 2173(93.89%) [91.87,95.43] 172(.11%) [4.572,8.13]
 Terai 1865(92.22%) [90.53,93.63] 238(7.78%) [5.709,7.829]
Residence
 Rural 540(93.69%) [84.58, 90.01] 77(6.31%) [9.99,15.42] 0.06
 Urban 4083(93.27%) [91.27, 92.84] 351(6.73%) [7.16, 8.73]
Behavioural Characteristics
Current Tobacco Consumption
 No 3234(93.17%) [91.79,94.33] 318(6.83%) [5.668,8.206] 0.649
 Yes 1389(93.64%) [91.73,95.13] 110(6.36%) [4.865,8.267]
Alcohol Consumption (Past 30 days)
 No 3670(93.23%) [91.93,94.34] 347(6.78%) [5.658,8.075] 0.749
 Yes 953(93.6%) [91.33,95.31] 81(6.4%) [4.692,8.668]
Fruit and vegetable consumption
 Sufficient (≥5 serving) 131(93.77%) [86.2,97.32] 13(6.23%) [2.682,13.8] 0.852
 Insufficient(<5serving) 4471(93.26%) [92.09,94.27] 415(6.74%) [5.735,7.911]
Physical Activity (MET/Week)
 Adequate(≥600meq/hr.) 4223(93.48%) [92.31,94.48] 379(6.52%) [5.516,7.693] 0.276
 Inadequate(<600meq/hr.) 316(91.3%) [86.05,94.7] 39(8.7%) [5.3,13.95]

*p < 0.05; ** p < 0.01; *** p0.001.

Bold: Shows significant value.

The bivariate analysis of Metabolic Syndrome and socio-demographic variables revealed that prevalence of Metabolic Syndrome was significantly higher (11.95%) among participants aged 45–69 years increasing steadily with age The prevalence of Metabolic Syndrome was notably double among women (8.62%;95%CI) and significantly decreased with higher education attainment. Mets was particularly prevalent among individuals who were illiterate or had less than primary education (8.81%;95%CI) and was more common among those who were divorced/separated/widow (13.6%;95%CI).Additionally, it was frequently observed among participants residing in Terai region(7.77%;95%CI) and among those in the wealthiest quintile(11.78%;95%CI). Metabolic syndrome showed significantly associations with age (p ≤ 0.001), sex (p ≤ 0.012), education (p ≤ 0.018), marital status (p ≤ 0.001), geographical region(p ≤ 0.003) and household assets in quintiles (p ≤ 0.001), all at a significance level of p ≤ 0.05

Table 1 summarizes the prevalence of Metabolic Syndrome and its associated factors related to behavioral characteristics. The prevalence of MetS was higher among individuals who consume Tobacco (6.82%) and Alcohol in past 30 days (6.76%). Additionally, the prevalence of Mets was greater among those insufficient fruit and vegetables intake and insufficient physical activity (6.74%) and (6.22%) respectively (Table 1).

Multivariate analysis of factors associated with Metabolic Syndrome

Multivariate analysis revealed a significant association between age (p < 0.001) and Metabolic Syndrome. Participants aged 30–44 years exhibited odds of developing Metabolic Syndrome that were 3.68 times higher (p-value: < 0.001, 95% CI: 1.94,6.99) compared to those ages 15–29 years. Similarly, participants aged 45–69 years had odds 5.79 times higher (p-value: < 0.001, 95% CI: 2.77, 10.41) than the younger cohort.These findings were adjusted for variables including sex, marital status, education, residence, geographical regions, wealth index, current tobacco use, alcohol consumption in the past 30 days, fruit and vegetable intake and weekly physical activity. The cumulative risk for Metabolic Syndrome increased with advancing age.

A significant association was observed between sex (p < 0.001) and Metabolic Syndrome indicating that the risk for Metabolic Syndrome was 2.45 times higher among women (95% CI:1.57,3.51) after adjusting for age, residence, marital status, geographical region, wealth index, current tobacco use, alcohol consumption in the past 30 days, fruit and vegetable intake and weekly physical activity (Table 1).

The prevalence of Metabolic Syndrome was significantly associated with geographical region (p ≤ 0.02, 95% CI: 1.06,3.99) indicating that the risk for Metabolic Syndrome was 2.06 times higher among individuals living in the Terai region and 1.68 times higher among participants living in mountainous region after controlling for age, sex, residence, marital status, wealth index, current tobacco use, alcohol consumption in the last 30 days, fruit and vegetable consumption and weekly physical activity.

The risk of Metabolic Syndrome significantly increased with higher wealth quintile (p < 0.05;95% CI). Individuals in the fourth wealth quintile exhibited a 2.43-fold increased risk of Metabolic Syndrome. (p < 0.006; 95%CI:1.29,4.60) while those in the richest wealth quintile had a 4.12 fold higher risk compared to the individuals in the poorest wealth quintile (p < 0.001;95% CI:2.30,7.39) after adjusting for age, sex, residence, marital status, geographical region, current use of tobacco product, alcohol consumption in last 30 days, fruits and vegetable consumption, adequate physical activity.

Age, sex, wealth quintile and geographical region were at increased risk of Metabolic Syndrome (Table 2).

Table 2. Multivariate analysis of socio-demographic and behavioral factors associated with Metabolic Syndrome, n = 5051.

Socio-Demographic Factors Adjusted Odds Ratio (AOR) 95% CI p-value
Age (in years)
 15-29 1
 30-44 3.67 2.09,6.45*** <0.001
 45-69 5.79 3.32,10.11*** <0.001
Sex
 Men 1
 Women 2.46 1.58,3.82*** <0.001
Residence
 Urban 1
 Rural 1.48 0.93,2.35 0.098
Marital status
 Never married 1
 Currently married 0.84 0.35,2.04 0.699
 Divorced/separated/Widow 1.21 0.48,3.08 0.684
Education
 Illiterate/ > Primary 1
 Primary 1 0.63, 1.58 0.995
 <Secondary 0.8 0.48, 1.33 0.379
 ≥Secondary 0.79 0.38, 1.64 0.518
Wealth Index
 Poorest 1
 Second 1.42 0.85,2.36 0.178
 Middle 1.74 0.89,3.41 0.107
 Fourth 2.44 1.29,4.60** 0.006
 Richest 4.13 2.30,7.39*** <0.001
Geographical Region
 Mountain 1
 Hills 1.69 0.88, 3.25 0.116
 Terai 2.06 1.08, 3.95* 0.029
Behavioural Characteristics
Tobacco consumption
 No 1 0.68, 1.54 .0.92
 Yes 1.02
Alcohol Consumption (past 30 days)
 No 1 0.84,1.99 0.243
 Yes 1.29
Intake of Fruit and vegetable
 Sufficient (≥3 Servings) 1 0.79,4.82 0.147
 Insufficient (<3 Servings) 1.95
Physical activity (MET/Week)
 Adequate (≥600MET/Week) 1 0.63, 1.94 0.779
 Inadequate (<600 MET/Week) 1.11

*p < 0.05; ** p < 0.01; *** p0.001

Bold: Shows significant value.

Adjusted for age, sex, education, marital status, wealth index, geographical regions, residence, tobacco consumption, Alcohol consumption, fruits and vegetables intake, weekly physical activity.

Frequency distribution of several components of Metabolic Syndrome

The overall Prevalence of Metabolic Syndrome was 6.6%; 95% CI. The Prevalence was significantly double (8.62%;95%CI) among women as compared to men (4.2%;95%CI). The most prevalent component was High Waist Circumference (63.6%) that was significantly high among women followed by High Blood Pressure (29.8.%;95% CI) which was significantly high among men. Total Cholesterol (10.8%; 95%CI) was observed in both Sex which was significantly high (13.9%; 95% CI) among women. Among the components observed, high blood glucose was least prevalent (6.3%; 95% CI) in both sex which was observed more (5.3%; 95%CI) among the women. Majority (93.4%; 95% CI) of respondents had less than 3 components and was significantly less among Men (Table 3).

Table 3. Frequency distribution of various components of Metabolic Syndrome.

Metabolic components Women% Men% Both Sex% p-value
High waist Circumference(n = 5518) 70.2 56.3 63.6 <0.001***
High blood pressure (n = 5506) 19.7 29.8 24.75 <0.001***
High Total Cholesterol (n = 5342) 13.9 7.7 10.8 <0.001***
High blood Glucose(n = 5191) 5.3 4.2 6.3 0.282
Metabolic Syndrome (n = 5051) 8.62 4.57 6.6 <0.001***
0 or < 3 components (n = 5051) 51.21 48.79 93.4 <0.001***

* p < 0.05; p < 0.01**; p < 0.001***.

Clustering of components of Metabolic Syndrome

A triad consisting of blood pressure, blood sugar and total cholesterol (n = 219) was identified in 3.59% of participants with a higher prevalence among women (54.85%) followed by triad of waist hip circumference, blood pressure and blood sugar (n = 185) was observed in 3% participants and was significantly more prevalent among women. The triad involving waist circumference, blood pressure and total cholesterol (n = 134) appeared in 1.94% of population again, showing a significantly higher prevalence among women. The least common triad comprising high waist circumference, elevated blood sugar and high total cholesterol (n = 97) was found in 1.41% of participants with a notable prevalence among women. Overall, the clustering of all four components (high waist circumference +Elevated Blood Pressure+ high blood sugar+ elevated total cholesterol) was observed in 1.09% participants with a significant predominance among women. Therefore, the clustering of components of Metabolic Syndrome components was more pronounced in women (Table 4). Each triad of components demonstrated a significant association with MetS at p < 0.01.

Table 4. Frequency distribution of triad components of Metabolic Syndrome.

Clustering of Metabolic components Women
n%
Men
n%
p-value
High Waist circumference +high Blood pressure+ high Total cholesterol (n = 134) 89.49 10.51 <0.001***
High Waist Circumference + high Blood Pressure+ High Blood sugar (n = 185) 90.49 26.86 0.006**
High Waist Circumference + High Blood Sugar + High Total Cholesterol (n = 97) 91.49 14.26 <0.001***
High Blood Pressure+ High Blood Sugar + High Total Cholesterol (n = 219) 92.49 41.92 <0.001***
High Waist Circumference + High Blood Pressure+ High Blood Sugar+ High Total Cholesterol (n = 66) 93.49 17.03 <0.001***

*p < 0.05; **p < 0.01; ***p < 0.001.

Discussion

Based on the data from STEPS survey conducted in 2019, the overall prevalence of MetS was higher; however, it was comparatively lower than in other South Asian countries [14], Asia Pacific region, China and ten European countries, as reported in a systematic review where the prevalence ranged from 11.5% to 37.5% [15,26,27]. Notably, there was a downward trend in the prevalence of MetS, decreasing from 14.1% to 6.2%.Beltrán-Sánchez H et.al. proved similar finding in the United States [28]; however, this contrast with the study conducted in Bangladesh [29] Finland [30] Korea [30] Taiwan [31] and Poland [32] where increase in the prevalence of MetS was observed. The decline in the trend of prevalence MetS in Nepal may be attributed to a 50% reduction in total cholesterol levels in 2019 compared to the STEPS Survey in 2013 [22,33] as well as potential differences in measurement criteria.

Understanding the factors associated with MetS is crucial for its prevention. The prevalence of Metabolic Syndrome has been linked to various socio-demographic factors. In alignment, with the research conducted in Nepal by Mehata. S. et al. [33] socio-demographic characteristics such as age, sex, education, marital status and geographical region were found to have significant associations with MetS. Additionally, the study indicated that an increase in assets was correlated with MetS corroborating findings from research in China by Yao F, et al. [26]. Therefore, it is essential to further investigate the role of socio-demographic determinants related to MetS.

In the current study, behavioral factors showed no association with Metabolic Syndrome (MetS). However, a high prevalence of MetS was observed among individuals who didn’t consume sufficient fruits and vegetables and who engaged in inadequate physical activity. Conversely, a lower prevalence of MetS was noted among tobacco and alcohol consumers which aligns with findings from a study conducted in the United States [34]. It is important to note that various studies have linked MetS to behavioral factors [35–37].

Metabolic Syndrome prevalence was nearly double among women compared to men with the three most prevalent metabolic components among women being high waist circumference, elevated total cholesterol levels and high blood glucose levels which was consistent to the study conducted in India [38,39] but contrasts with research from China [40]. The prevalent of metabolic abnormalities in women may be related to advancing age, as physiological changes such as decreased circulating estrogen levels can increase cardiovascular risk through their effects on adiposity and lipid metabolism. The observed sex differences may stem both biological and behavioral factors [41].

Factors associated with Non-Communicable Diseases among women include prolonged working hours, the dual burden of work and household responsibilities and stress which hinder time for physical fitness [42]. The prevalence of physical inactivity doubled in the STEPS survey 2019, with higher rates observed among women. Exercise training has been shown to improve body composition, cardiovascular health and metabolic outcomes in individuals with MetS [43]. Additionally, prevalence is associated with higher wealth quintiles [44], unemployment, easy access to transportation, lower social classes as classified by education and occupation [45]. Further exploration of various behavioral factors contributing to Metabolic Syndrome among women is warranted.

The prevalence of Metabolic Syndrome increases progressively with age reaching significant levels between the ages of forty and sixty, consistent with findings of Anguliar M. et. al. and Ogbera AO [46,47]. This trend may be attributed to ageing process, which is associated with increased adiposity leading to stagnant of adipose tissue and pathological hormonal deficiencies. Additionally, the rise in pro-inflammatory factors with aging disrupts insulin receptor signaling in adipose tissues, contributing to the development of diabetes and other metabolic diseases [48,49]. Preventive measures of Metabolic Syndrome at an early age can be achieved through health awareness and lifestyle modification.

The current study revealed educational attainment as a significant determinant of Metabolic Syndrome (MetS), which has a notably high prevalence, was observed among participants with less than a primary education level. This study is consistent which the study in China which also found that lower education levels were associated with an increased risk of MetS [50]. This correlation may be attributed to the greater accessibility of awareness and concern among individuals of higher education levels, enabling them to adopt effective health preventive and promotive measures [19]. Moreover, participants with higher education levels tend to smoke less, maintain a higher quality diet and engage in less excessive alcohol consumption [51].

The likelihood of developing Metabolic Syndrome (MetS) was significantly higher among divorced/ separated women compared to those who have ever been married or are currently married. This finding aligns with a study conducted in Korea, which indicated that married and widowed middle-aged women exhibited a higher risk of Metabolic Syndrome potentially linked to socioeconomic factors [52,53], health behaviors [54] and marital distress [55]. Furthermore, high-quality marriages are at associated with a lower risk of MetS among women [56].

The odds of having Metabolic Syndrome were more than double in the fourth quintile and over four times higher in the richest quintile compared to the poorest quintile. This finding aligns with the study indicating that sedentary behaviors [50], health related problems [57], low levels of physical activity [58], stress and dietary habit are more prevalent among individuals with increased assets [59,60].

Furthermore, Metabolic Syndrome was found to be ecologically associated consistent with research demonstrating a higher prevalence of multi-morbidity at low altitudes [61]. The terai region, situated at a low altitude is influenced by culture and traditional practices related to food preparation and consumption, dietary habits, behavioral risk factors, climate and stress all of which contribute to an increased the risk of Non-Communicable Diseases(NCDs) [62–64].Conversely, urbanization, mostly rurality and high-altitude environments(≥2,500 meters above sea level) were independently associated with a reduced predicted cardiovascular risk [65–66].

Conclusion

The present study indicates a decrease in the trend of Metabolic Syndrome from 2013-2019. However, the prevalence of Metabolic Syndrome and its individual components remain high. Women exhibit a higher prevalence as well as greater components of Mets. High waist circumference among women and high blood pressure among are significant predictors. In this study, MetS was not influenced by behavioral factors. Socio-demographic factors such as age, sex, education, marital status, wealth quintile and geographical region suggest a need for further exploration of the association between demographic factors and MetS. The high prevalence of MetS among non-alcoholic and non-tobacco consumers warrant additional research. Marital status appears to be associated with cardiovascular disease among women, highlighting the urgency for lipid screening and educational programs. The current health plan could incorporate MetS screening utilizing total cholesterol levels to mitigate the economic burden of cardiovascular-related issues, particularly, for the targeted population aged 40 and above. The inclusion of MetS Screening in WHO PEN module package could benefit low- and middle-income countries by reducing cardiovascular-related mortality and morbidity.

Recommendations

High Waist Circumference among women underscores the urgency of prioritizing the management of abdominal obesity within healthcare. Although, modifiable risk factors did not demonstrate significant difference with the prevalence of Metabolic Syndrome (MetS), it was observed that the prevalence of MetS was higher among individuals who did not consume tobacco or alcohol. Conversely, individuals engaging in adequate physical activity and consuming adequate fruits and vegetables exhibit a lower prevalence of MetS. Enhancing awareness regarding appropriate physical activity and nutritional intake is crucial in mitigating the burden of MetS. To effectively address this issue, the country should strengthen community-level health centers to implement screening measures for MetS, thereby reducing the burden of cardiovascular diseases. While the National Health Policy has introduced a national insurance program, out-of-pocket model expenditure remains prevalent in healthcare. Routine screening for MetS into the National Health Insurance program could significantly benefit the population and contribute to reducing the cardiovascular disease burden in Nepal.

Strengths and limitations

The study was a population-based survey with large sample size, allowing generalization of the findings. It represents the only analysis of trends and the association between the wealth quintile and MetS in Nepal. Following the statistical assessment of the relationship between raised total cholesterol, triglycerides and HDL-C recommendations for cost-effective methods of MetS screening were provided. However, despite its valuable contributions, the study has certain limitations. It is secondary analysis and a cross-sectional study. Additionally, total cholesterol was used instead of HDL-C and triglycerides to determine the prevalence of MetS.

Supporting information

S1 Table. Variable definition of Metabolic Syndrome.

The variable definition for components of Metabolic Syndrome with their parameter are defined in the table.

(TIF)

pgph.0004003.s001.tif (1.9MB, tif)
S2 Table. Variable definition of behavioral factors.

The behavioral factors in the study are presented in the table.

(TIF)

pgph.0004003.s002.tif (1.5MB, tif)
S1 Fig. ROC Curve predicting Area Under curve for TC over Tg.

Receiver Operating Characteristic (ROC) Curve analysis revealed an Area Under the Curve (AUC) of 0.75 for Total Cholesterol predicting triglyceride (p < 0.001)].

(TIF)

pgph.0004003.s003.tif (586.6KB, tif)
S2 Fig. ROC Curve for Area Under Curve for TC over HDL-C.

Area Under the Curve of 0.71 for total cholesterol predicting high density lipoprotein –cholesterol (HDL-C) (p < 0.001).

(TIF)

pgph.0004003.s004.tif (867.4KB, tif)
S3 Table. Chi-square table for association of TC and Tg Chi-square test demonstrated strong significant association between TC (Total Cholesterol) and Tg (Tri-glyceride) at p ≤ 0.001.

There is more than 3 times risk of having Triglyceride with a single rise in Total Cholesterol level.

(TIF)

pgph.0004003.s005.tif (637.7KB, tif)
S4 Table. Chi-square table for association of TC and HDL-C Men.

There is a significant association between Total Cholesterol(TC)and HDL-C(High Density Lipoprotein-Cholesterol) among men at p ≤ 0.001. Men with increased TC level are more than 1.5 times greater risk of having HDL-C.

(TIF)

pgph.0004003.s006.tif (1.4MB, tif)
S5 Table. Chi-square table for association of TC and HDL-C Women.

There is strong significant association between Total Cholesterol (TC) level and (High Density Lipoprotein-Cholesterol) HDL-C level among women at p p ≤ 0.001.

(TIF)

pgph.0004003.s007.tif (765.2KB, tif)
S6 Table. Correlation of HDL-C,TC and Tg Correlation analysis between total cholesterol, triglycerides and (HDL-C) ““S6 Table”” supporting the notion that increased total cholesterol can serve as a predictor for elevated triglycerides and HDL-C.

(TIF)

pgph.0004003.s008.tif (471.5KB, tif)

Acknowledgments

The author wishes to acknowledge University Grant Commission for providing a partial scholarship grant and expresses gratitude to the Nepal Health Research Council and the World Health Organization for providing raw data. The author also appreciates the University of Cyberjaya for its essential support throughout the study.

Data Availability

The data can be assessed from WHO Microdata Repository STEPS Survey 2013 and 2019. The data agreement for STEPS 2019 was done from Nepal Health Research Council and the data was directly accessed from there.The agreement file has been uploaded as other types. However, STEPS 2013 data was accessed directly from https://extranet.who.int/ncdsmicrodata/index.php/catalog/STEPS/?page=1&sk=Nepal&ps=15&repo=STEPS.

Funding Statement

The author(s) received partial scholarship from University Grant Commission, Nepal for the study. However, the scholarship fund is utilized for the research purpose.

References

  • 1.WHO. World Health Organization. Package of Essential Noncommunicable (PEN) Disease Intervention for Primary Health Care. 2020. [Google Scholar]
  • 2.Murray CJL. The Global Burden of Disease Study at 30 Years. Nat Med. 2022;28(10):2019–26. [DOI] [PubMed] [Google Scholar]
  • 3.Pandey AR, Chalise B, Shrestha N, Ojha B, Maskey J, Sharma D, et al. Mortality and risk factors of disease in Nepal: Trend and projections from 1990 to 2040. PLoS One. 2020;15(12):e0243055. doi: 10.1371/journal.pone.0243055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Choo J, Yoon SJ, Ryu H, Park MS, Lee HS, Park YM, et al. The Seoul Metropolitan Lifestyle Intervention Program and Metabolic Syndrome Risk: A Retrospective Database Study. [DOI] [PMC free article] [PubMed]
  • 5.Sapkota BP, Baral KP, Rehfuess EA, Parhofer KG, Berger U. Effects of age on non-communicable disease risk factors among Nepalese adults. PLoS One. 2023;18(6):e0281028. doi: 10.1371/journal.pone.0281028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288(21):2709–16. [DOI] [PubMed] [Google Scholar]
  • 7.Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev. 2007;23(2):127–34. doi: 10.1002/dmrr.658 [DOI] [PubMed] [Google Scholar]
  • 8.Kurl S, Laaksonen DE, Jae SY, Mäkikallio TH, Zaccardi F, Kauhanen J, et al. Metabolic syndrome and the risk of sudden cardiac death in middle-aged men. Int J Cardiol. 2016;203:792–7. [DOI] [PubMed] [Google Scholar]
  • 9.McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28(2):385–90. doi: 10.2337/diacare.28.2.385 [DOI] [PubMed] [Google Scholar]
  • 10.Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssönen K, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006;37(3):806–11. doi: 10.1161/01.STR.0000204354.06965.44 [DOI] [PubMed] [Google Scholar]
  • 11.Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J Am Med Assoc. 2002;288(21):2709–16. [DOI] [PubMed] [Google Scholar]
  • 12.Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. Metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–32. [DOI] [PubMed] [Google Scholar]
  • 13.Prasad DS, Kabir Z, Dash AL, Das BC. Prevalence and risk factors for metabolic syndrome in Asian Indians: A community study from urban Eastern India. J Cardiovasc Dis Res. 2012;3(3):204–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Aryal N, Wasti SP. The prevalence of metabolic syndrome in South Asia: a systematic review. Int J Diabetes Dev Ctries. 2016;36(3):255–62. [Google Scholar]
  • 15.Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. Metabolic syndrome in South Asians. Indian J Endocrinol Metab. 2012;16(1):44–55. doi: 10.4103/2230-8210.91187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mehata S, Shrestha N, Mehta RK, Bista B, Pandey AR, Mishra SR. Prevalence of the metabolic syndrome and its determinants among Nepalese adults: findings from a nationally representative cross-sectional study. Sci Rep. 2018;8(1):1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sullivan DR. Screening for cardiovascular disease with cholesterol. Clin Chim Acta. 2002;315(1–2):49–60. doi: 10.1016/s0009-8981(01)00720-3 [DOI] [PubMed] [Google Scholar]
  • 18.Scott CL. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol. 2003;92(1A):35i–42i. doi: 10.1016/s0002-9149(03)00507-1 [DOI] [PubMed] [Google Scholar]
  • 19.Yu M, Xu CX, Zhu HH, Hu RY, Zhang J, Wang H. Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: A cross-sectional study. J Epidemiol. 2014;24(5). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Vaidya A. Tackling cardiovascular health and disease in Nepal: epidemiology, strategies and implementation. Heart Asia. 2011;3(1):87–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.St E 21, Aryal KK, Neupane S, Mehata S, Vaidya A, et al. Non-communicable Diseases Risk Factors: STEPS Survey Nepal 2013. World Health Organization Country Office for Nepal. [Google Scholar]
  • 22.Dhimal M, Karki KB, Sharma SK, Aryal KK, Shrestha N, Poudyal A, et al. Prevalence of Selected Chronic Non-Communicable Diseases in Nepal. J Nepal Health Res Counc. 2019;17(3):394–401. doi: 10.33314/jnhrc.v17i3.2327 [DOI] [PubMed] [Google Scholar]
  • 23.Bista B, Dhimal M, Bhattarai S, Neupane T, Xu YY, Pandey AR, et al. Prevalence of non-communicable diseases risk factors and their determinants: Results from STEPS survey 2019, Nepal. PLoS One. 2021;16(7):e0253605. doi: 10.1371/journal.pone.0253605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Noncommunicable Disease Surveillance, Monitoring and Reporting [Internet]. [cited 2025 Aug 27]. Available from: https://www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps
  • 25.Catalog history. [cited 2025 August 27]. https://extranet.who.int/ncdsmicrodata/index.php/catalog/history/?per_page=300
  • 26.Yao F, Bo Y, Zhao L, Li Y, Ju L, Fang H. Prevalence and influencing factors of metabolic syndrome among adults in China from 2015 to 2017. Nutrients. 2021;13(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):101. doi: 10.1186/s12889-017-4041-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999-2010. J Am Coll Cardiol. 2013;62(8):697–703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chowdhury MZI, Anik AM, Farhana Z, Bristi PD, Abu Al Mamun BM, Uddin MJ. Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. BMC Public Health. 2018;18(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lehtoranta L, Jääskeläinen T, Palosaari T, Männistö S, Sääksjärvi K, Lahti J. Metabolic syndrome prevalence has increased in Finland from 2000 to 2023. The European Journal of Public Health. 2024;34(Suppl 3):ckae144.330. [Google Scholar]
  • 31.Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017;17(1):101. doi: 10.1186/s12889-017-4041-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Rajca A, Wojciechowska A, Śmigielski W, Drygas W, Piwońska A, Pająk A. Increase in the prevalence of the metabolic syndrome in Poland. Comparison of the results of the WOBASZ (2003–2005) and WOBASZ II (2013–2014) studies. Pol Arch Med Wewn. 2021;131(6):520–6. [DOI] [PubMed] [Google Scholar]
  • 33.Mehata S, Shrestha N, Mehta RK, Bista B, Pandey AR, Mishra SR. Prevalence of the Metabolic Syndrome and its determinants among Nepalese adults: Findings from a nationally representative cross-sectional study. Sci Rep. 2018;8(1):14995. doi: 10.1038/s41598-018-33177-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bhanushali CJ, Kumar K, Wutoh AK, Karavatas S, Habib MJ, Daniel M, et al. Association between Lifestyle Factors and Metabolic Syndrome among African Americans in the United States. J Nutr Metab [Internet]. 2013 [cited 2025 Aug 27]; 2013:1–6. Available from: http://www.hindawi.com/journals/jnme/2013/516475/ [DOI] [PMC free article] [PubMed]
  • 35.Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, et al. Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One. 2012;7(4):e34916. doi: 10.1371/journal.pone.0034916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Krishnamoorthy Y, Rajaa S, Murali S, Rehman T, Sahoo J, Kar SS. Prevalence of metabolic syndrome among adult population in India: A systematic review and meta-analysis. PLoS One. 2020;15(10):e0240971. doi: 10.1371/journal.pone.0240971 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Deng Y, Yang Q, Hao C, Wang HH, Ma T, Chen X, et al. Combined lifestyle factors and metabolic syndrome risk: a systematic review and meta-analysis. Int J Obes. 2025;49(2):226–36. [DOI] [PubMed] [Google Scholar]
  • 38.Deng YY, Ngai FW, Qin J, Yang L, Wong KP, Wang HH. Combined influence of eight lifestyle factors on metabolic syndrome incidence: A prospective cohort study from the MECH-HK study. Nutrients. 2024;16(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Krishnamoorthy Y, Rajaa S, Murali S, Sahoo J, Kar SS. Association between behavioural risk factors and metabolic syndrome among adult population in India: A systematic review and meta-analysis of observational studies. Nutr Metab Cardiovasc Dis. 2022;32(1):40–52. doi: 10.1016/j.numecd.2021.09.006 [DOI] [PubMed] [Google Scholar]
  • 40.Lan Y, Mai Z, Zhou S, Liu Y, Li S, Zhao Z, et al. Prevalence of metabolic syndrome in China: An up-dated cross-sectional study. PLoS One. 2018;13(4):e0196012. doi: 10.1371/journal.pone.0196012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Sex differences in risk factors for metabolic syndrome in the Korean population. International Journal of Environmental Research and Public Health. 2020;17(24):9513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Idris IB, Azit NA, Abdul Ghani SR, Syed Nor SF, Mohammed Nawi A. A systematic review on noncommunicable diseases among working women. Ind Health. 2021;59(3):146–60. doi: 10.2486/indhealth.2020-0204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ostman C, Smart NA, Morcos D, Duller A, Ridley W, Jewiss D. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16(1):110. doi: 10.1186/s12933-017-0590-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Santos AC, Ebrahim S, Barros H. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health. 2008;8:62. doi: 10.1186/1471-2458-8-62 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustafsson K, Orth-Gomér K. Education and the metabolic syndrome in women. Diabetes Care. 1999;22(12):1999–2003. doi: 10.2337/diacare.22.12.1999 [DOI] [PubMed] [Google Scholar]
  • 46.Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr. 2010;2:1. doi: 10.1186/1758-5996-2-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973–4. [DOI] [PubMed] [Google Scholar]
  • 48.Yu P, Yuan R, Yang X, Qi Z. Adipose tissue, aging, and metabolism. Curr Opin Endocr Metab Res. 2019;5:11–20. [Google Scholar]
  • 49.Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45. doi: 10.1146/annurev-immunol-031210-101322 [DOI] [PubMed] [Google Scholar]
  • 50.Zhan Y, Yu J, Chen R, Gao J, Ding R, Fu Y, et al. Socioeconomic status and metabolic syndrome in the general population of China: a cross-sectional study. BMC Public Health. 2012;12:921. doi: 10.1186/1471-2458-12-921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wang Y, Chen J, Wang K, Edwards CL. Education as an important risk factor for the prevalence of hypertension and elevated blood pressure in Chinese men and women. J Hum Hypertens. 2006;20(11):898–900. doi: 10.1038/sj.jhh.1002086 [DOI] [PubMed] [Google Scholar]
  • 52.Lim H, Nguyen T, Choue R, Wang Y. Sociodemographic disparities in the composition of Metabolic Syndrome components among adults in South Korea. Diabetes Care. 2012;35(10):2028–35. 10.2337/dc11-1841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yang JJ, Yoon HS, Lee SA, Choi JY, Song M, Han S, et al. Metabolic syndrome and sex specific socio-economic disparities in childhood and adulthood: the Korea National Health and Nutrition Examination Surveys. Diabetic Medicine. 2014;31(11):1399–409. doi: 10.1111/dme.12525 [DOI] [PubMed] [Google Scholar]
  • 54.Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, et al. Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One. 2012;7(4):e34916. 10.2337/de11-1841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Jung YA, Kang LL, Kim HN, Park HK, Hwang HS, Park KY. Relationship between marital status and metabolic syndrome in Korean middle-aged women: The sixth Korea national health and nutrition examination survey (2013–2014). Korean J Fam Med. 2018;39(5):307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Troxel WM, Matthews KA, Gallo LC, Kuller LH. Marital quality and occurrence of the metabolic syndrome in women. Archives of Internal Medicine. 2005;165(9):1022–7. [DOI] [PubMed] [Google Scholar]
  • 57.Leyland AH. Socioeconomic gradients in the prevalence of cardiovascular disease in Scotland: the roles of composition and context. J Epidemiol Community Health. 2005;59(9):799–803. doi: 10.1136/jech.2005.034017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82(6):816–20. doi: 10.2105/ajph.82.6.816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ying X, Yang S, Li S, Su M, Wang N, Chen Y. Prevalences of metabolic syndrome and its sex-specific association with socioeconomic status in rural China: a cross-sectional study. BMC Public Health. 2021;21(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Egbujie BA, Igumbor EU, Puoane T. A cross-sectional study of socioeconomic status and cardiovascular disease risk among participants in the Prospective Urban Rural Epidemiological (PURE) Study. S Afr Med J. 2016;106(9):900–6. doi: 10.7196/SAMJ.2016.v106i9.10456 [DOI] [PubMed] [Google Scholar]
  • 61.Miranda JJ, Bernabe-Ortiz A, Gilman RH, Smeeth L, Malaga G, Wise RA, et al. Multimorbidity at sea level and high-altitude urban and rural settings: The CRONICAS Cohort Study. J Comorb. 2019;9:2235042X19875297. doi: 10.1177/2235042X19875297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Ghimire K, Adhikari TB, Rijal A, Kallestrup P, Henry ME, Neupane D. Knowledge, attitudes, and practices related to salt consumption in Nepal: Findings from the community-based management of non-communicable diseases project in Nepal (COBIN). J Clin Hypertens (Greenwich). 2019;21(6):739–48. doi: 10.1111/jch.13544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Ghimire K, Mishra SR, Satheesh G, Neupane D, Sharma A, Panda R, et al. Salt intake and salt-reduction strategies in South Asia: From evidence to action. J Clin Hypertens (Greenwich). 2021;23(10):1815–29. doi: 10.1111/jch.14365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Mohani S, Prabhakarani DP, Krishnani AK. Promoting populationwide salt reduction in the South-East Asia Region: current status and future directions. [cited 2025 August 27]. https://iris.who.int/bitstream/handle/10665/205784/B4954.pdf#page=78
  • 65.Bernabe-Ortiz A, Carrillo-Larco RM. Urbanization, altitude and cardiovascular risk. Glob Heart. 2022;17(1):42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Mallet RT, Burtscher J, Richalet J-P, Millet GP, Burtscher M. Impact of High Altitude on Cardiovascular Health: Current Perspectives. Vasc Health Risk Manag. 2021;17:317–35. doi: 10.2147/VHRM.S294121 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Variable definition of Metabolic Syndrome.

The variable definition for components of Metabolic Syndrome with their parameter are defined in the table.

(TIF)

pgph.0004003.s001.tif (1.9MB, tif)
S2 Table. Variable definition of behavioral factors.

The behavioral factors in the study are presented in the table.

(TIF)

pgph.0004003.s002.tif (1.5MB, tif)
S1 Fig. ROC Curve predicting Area Under curve for TC over Tg.

Receiver Operating Characteristic (ROC) Curve analysis revealed an Area Under the Curve (AUC) of 0.75 for Total Cholesterol predicting triglyceride (p < 0.001)].

(TIF)

pgph.0004003.s003.tif (586.6KB, tif)
S2 Fig. ROC Curve for Area Under Curve for TC over HDL-C.

Area Under the Curve of 0.71 for total cholesterol predicting high density lipoprotein –cholesterol (HDL-C) (p < 0.001).

(TIF)

pgph.0004003.s004.tif (867.4KB, tif)
S3 Table. Chi-square table for association of TC and Tg Chi-square test demonstrated strong significant association between TC (Total Cholesterol) and Tg (Tri-glyceride) at p ≤ 0.001.

There is more than 3 times risk of having Triglyceride with a single rise in Total Cholesterol level.

(TIF)

pgph.0004003.s005.tif (637.7KB, tif)
S4 Table. Chi-square table for association of TC and HDL-C Men.

There is a significant association between Total Cholesterol(TC)and HDL-C(High Density Lipoprotein-Cholesterol) among men at p ≤ 0.001. Men with increased TC level are more than 1.5 times greater risk of having HDL-C.

(TIF)

pgph.0004003.s006.tif (1.4MB, tif)
S5 Table. Chi-square table for association of TC and HDL-C Women.

There is strong significant association between Total Cholesterol (TC) level and (High Density Lipoprotein-Cholesterol) HDL-C level among women at p p ≤ 0.001.

(TIF)

pgph.0004003.s007.tif (765.2KB, tif)
S6 Table. Correlation of HDL-C,TC and Tg Correlation analysis between total cholesterol, triglycerides and (HDL-C) ““S6 Table”” supporting the notion that increased total cholesterol can serve as a predictor for elevated triglycerides and HDL-C.

(TIF)

pgph.0004003.s008.tif (471.5KB, tif)

Data Availability Statement

The data can be assessed from WHO Microdata Repository STEPS Survey 2013 and 2019. The data agreement for STEPS 2019 was done from Nepal Health Research Council and the data was directly accessed from there.The agreement file has been uploaded as other types. However, STEPS 2013 data was accessed directly from https://extranet.who.int/ncdsmicrodata/index.php/catalog/STEPS/?page=1&sk=Nepal&ps=15&repo=STEPS.


Articles from PLOS Global Public Health are provided here courtesy of PLOS

RESOURCES